Dr. Lufkin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5050 Ne Hoyt St Ste 256
Portland, OR 97213Phone+1 503-239-7767Fax+1 503-215-6897
Education & Training
UMass Chan - BaystateFellowship, Hematology and Medical Oncology, 2004 - 2007
Providence Health & Services - Oregon/St Vincent Hospital and Medical CenterResidency, Internal Medicine, 2000 - 2003
University of New England College of Osteopathic MedicineClass of 2000
Certifications & Licensure
OR State License 2002 - 2025
WA State License 2013 - 2025
MA State License 2004 - 2007
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- Safety and Tolerability of Carboxyamidotriazole Orotate (CTO) in Solid Tumors or With Temodar® in Glioblastoma or Other Recurrent Malignant Gliomas or in Combination With Temodar® and Radiation Therapy for Patients With Newly Diagnosed Glioblastoma and Malignant Gliomas
- Comparison of High-dose IL-2 and High-dose IL-2 With Radiation Therapy in Patients With Metastatic Melanoma. Start of enrollment: 2011 Jul 01
- Phase I Study of Safety and Immunogenicity of ADU-623 Start of enrollment: 2014 Jan 08
Publications & Presentations
PubMed
- 76 citationsDurable responses and reversible toxicity of high-dose interleukin-2 treatment of melanoma and renal cancer in a Community Hospital Biotherapy ProgramRoxanne Payne, Lyn A. Glenn, Helena M. Hoen, Beverley Richards, John W. Smith
Journal for Immunotherapy of Cancer. 2014-05-14
Press Mentions
Compound Extends Life, Combats Alzheimer’sMay 14th, 2024
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
